| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.4M | +0.0% |
| R&D Expense | $167.5M | +58.4% |
| SG&A Expense | $46.5M | +41.9% |
| Operating Income | -$214.1M | -65.7% |
| Pre-tax Income | -$182.7M | -45.9% |
| Income Tax | -$292K | -347.5% |
| Net Income | -$182.4M | -45.5% |
| EPS (Basic) | -$2.73 | -32.5% |
| EPS (Diluted) | -$2.73 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $148.6M | +159.7% |
| Short-term Investments | $489.4M | -8.5% |
| Accounts Receivable | $874K | -11.4% |
| Current Assets | $645.0M | +7.4% |
| Total Assets | $964.8M | +27.9% |
| Current Liabilities | $27.3M | +20.1% |
| Total Liabilities | $36.9M | +12.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$145.3M | -47.6% |
| Capital Expenditures | $5.6M | +94.1% |
| Investing Cash Flow | -$117.2M | +60.4% |
| Financing Cash Flow | $353.5M | +27.0% |
| Free Cash Flow | -$150.9M | -49.0% |
| -32.5% |
| Stockholders' Equity |
| $927.9M |
| +28.6% |